Guided Therapeutics Inc. (OTCMKTS:GTHP – Get Free Report) shares were up 1.4% during mid-day trading on Wednesday . The stock traded as high as $0.2028 and last traded at $0.2028. Approximately 2,919 shares changed hands during mid-day trading, a decline of 63% from the average daily volume of 7,910 shares. The stock had previously closed at $0.20.
Guided Therapeutics Price Performance
The firm’s 50 day moving average is $0.21 and its two-hundred day moving average is $0.29. The company has a market cap of $19.58 million, a P/E ratio of -5.07 and a beta of 0.74.
Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) last issued its earnings results on Friday, May 15th. The company reported ($0.01) EPS for the quarter.
About Guided Therapeutics
Guided Therapeutics, Inc is a medical device company focused on the development and commercialization of non‐invasive optical diagnostic platforms for women’s health. Its flagship product, the LuViva® Advanced Cervical Scan, combines hyperspectral and reflectance imaging to support the early detection of cervical epithelial abnormalities. By capturing tissue fluorescence and reflectance signatures in real time, LuViva is designed to augment traditional visual inspection methods and assist clinicians during colposcopic evaluations.
The company secured 510(k) clearance from the U.S.
Read More
- Five stocks we like better than Guided Therapeutics
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
